The Value of Multimodal Imaging in the Diagnosis and Monitoring of AMD and Geographic Atrophy
For the first time, the U.S. Food and Drug Administration (FDA) has approved a drug for the treatment of geographic atrophy (GA), one of the advanced forms of dry age-related macular degeneration (AMD).
![](https://www.heidelbergengineering.com/us/wp-content/themes/hdeng-corporate/assets/img/icon-link.png)